Sangamo Therapeutics (SGMOQ) Cash from Investing Activities (2009 - 2026)
Sangamo Therapeutics' Cash from Investing Activities came in at -$13,000 for Q1 2026.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Sangamo Therapeutics reported Cash from Investing Activities of -$115,000; for FY2025, it was -$102,000.
- Going back by year, Cash from Investing Activities was $37.52 million in FY2024 (-75.6%), $153.53 million in FY2023 (+159.0%), $59.29 million in FY2022 (-76.1%) and $248.2 million in FY2021.
- The Q1 2026 figure represents the highest quarterly Cash from Investing Activities since Q4 2024.
- The fastest year-over-year change in Cash from Investing Activities over five years came in Q2 2023 (growth of 49.4%), and the weakest in Q2 2024 (a decline of 99.7%).
- Business Quant data shows SGMOQ's Cash from Investing Activities at -$14,000 (Q4 2025), -$64,000 (Q3 2025) and -$24,000 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -8.30 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -2.71 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -10.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -1.32 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -649.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -244.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.03 Bn |
| 10 | Sangamo Therapeutics | 45.57 Mn | -70.94 Mn | - | -13,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Sep 30, 2025 | -64,000.00 |
| Jun 30, 2025 | -24,000.00 |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 233,000.00 |
| Jun 30, 2024 | 127,000.00 |
| Mar 31, 2024 | 35.84 Mn |
| Dec 31, 2023 | 37.71 Mn |
| Sep 30, 2023 | 37.63 Mn |
| Jun 30, 2023 | 42.47 Mn |
| Mar 31, 2023 | 35.73 Mn |
| Dec 31, 2022 | 42.61 Mn |
| Sep 30, 2022 | -13.46 Mn |
| Jun 30, 2022 | 28.43 Mn |
| Mar 31, 2022 | 1.71 Mn |
| Dec 31, 2021 | 52.64 Mn |
| Sep 30, 2021 | 60.98 Mn |
| Jun 30, 2021 | 89.30 Mn |
| Mar 31, 2021 | 45.29 Mn |
API Access
Sangamo Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();